Spots Global Cancer Trial Database for scc
Every month we try and update this database with for scc cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Treatment With Nab-paclitaxel in Cutaneous SCC | NCT02076243 | Cutaneous Squam... | nab-paclitaxel | 18 Years - | Icahn School of Medicine at Mount Sinai | |
ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients | NCT03689712 | Oral Mucositis | GC4419 90mg Placebo | 18 Years - | Galera Therapeutics, Inc. | |
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia | NCT04534127 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC | NCT05047094 | Head and Neck S... Skin Cancer Metastatic Head... | Diffusing Alpha... Pembrolizumab | 18 Years - | Alpha Tau Medical LTD. | |
Retreatment With Intratumoral Diffusing Alpha Radiation Emitters | NCT04540588 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
Pilot Study of PDL to Treat BCC and SCCIS | NCT01245972 | Basal Cell Carc... Squamous Cell C... | PDL Treatment | 18 Years - | University of California, San Diego | |
Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck | NCT01491139 | Carcinoma, Squa... | olaparib cisplatin Intensity Modul... | 18 Years - | University College, London | |
Pilot Study of PDL to Treat BCC and SCCIS | NCT01245972 | Basal Cell Carc... Squamous Cell C... | PDL Treatment | 18 Years - | University of California, San Diego | |
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia. | NCT03889899 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
3D Ultrasound, Specimen Examination by Surgeon, and MRI in Surgical Margin Assessment | NCT05843032 | Squamous Cell C... Tongue SCC Head and Neck C... | 3D ultrasound, ... | 18 Years - | Rigshospitalet, Denmark | |
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT) | NCT03886181 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Device: Radiati... | 18 Years - | Alpha Tau Medical LTD. | |
Bispecific PSMAxCD3 Antibody CC-1 in Patients With Squamous Cell Carcinoma of the Lung | NCT04496674 | Lung Cancer Squ... | CC-1 and Toczil... | 18 Years - | German Cancer Research Center | |
Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung | NCT01561456 | Non-small-cell ... Squamous Cell C... Adenocarcinoma ... | AXL1717 Docetaxel | 18 Years - | Axelar AB | |
Pilot Study of PDL to Treat BCC and SCCIS | NCT01245972 | Basal Cell Carc... Squamous Cell C... | PDL Treatment | 18 Years - | University of California, San Diego | |
Microwave Treatment for Actinic Keratosis | NCT05636800 | Keratosis, Acti... | Swift System | 18 Years - 85 Years | Blackwell Device Consulting | |
Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and Neck | NCT01275183 | Head and Neck C... | raltegravir and... | 18 Years - | New Mexico Cancer Care Alliance | |
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT) | NCT03886181 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Device: Radiati... | 18 Years - | Alpha Tau Medical LTD. | |
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT) | NCT03737734 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell Line | NCT05456022 | Oral Cancer | Quercetin 3,3',... Quercetin-encap... Doxorubicin che... | - | Cairo University | |
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia. | NCT03889899 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the Lip | NCT00868088 | Actinic Cheilit... Squamous Cell C... Squamous Cell C... Photodynamic Th... Mohs Surgery | PDT prior to Mo... | 18 Years - | Tufts Medical Center | |
Molecular Characterization of Cutaneous Tumors | NCT03092830 | Squamous Cell C... Basal Cell Carc... | Molecular testi... | 18 Years - | Rabin Medical Center | |
Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck | NCT01491139 | Carcinoma, Squa... | olaparib cisplatin Intensity Modul... | 18 Years - | University College, London | |
SymptomCare@Home: Deconstructing an Effective Symptom Management Intervention | NCT02779725 | Cancer | SCC Nurse Practitio... DSS AT Symptom Severit... | 18 Years - | University of Utah |